1. WHO. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation on rheumatic fever and rheumatic heart disease. World Health Organization. Geneva, 2001, Oct 29–Nov 1. Geneva: WHO, 2004.
Gewitz, MH, Baltmore, RS, Tani, LY, et al. On behalf of the American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation
2015; 131: 1806–1818.
Carapetis, JR, Steer, AC, Mulholland, EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis
2005; 5: 685–694.
Steer, AC, Carapetis, JR, Nolan, TM, et al. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child Health
2002; 38: 229–234.
Czoniczer, G, Amezcua, F, Pellargonio, S, et al. Therapy of severe rheumatic carditis. Comparison of adrenocortical steroids and aspirin. Circulation
1964; 29: 813–819.
Torres, RSLA, Torres, RPA, Smeesters, PR, et al. Group A Streptococcus antibiotic resistance in southern Brazil: a 17-year surveillance study. Microb Drug Resist
2011; 17: 313–319.
Kumar, RK, Tandon, R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J Med Res
2013; 137: 643–658.
Cilliers, A, Adler, AJ, Saloojee, H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev
2015; 5: 1–56.
Couto, AA, Martins, JC, Mansur, EM, et al. High-dose intravenous methylprednisolone (pulsetherapy): possible therapeutic solution for active rheumatic fever with severe carditis. Arq Bras Cardiol
1984; 43: 97–101.
Markowitz, M, Gordis, L. Rheumatic fever. Major Probl Clin Pediatr
1972; 11: 1–309.
Herdy, GV, Couto, AA, Fernandes, JC, et al. Pulse therapy (high venous of venous methylprednisolone) in children with rheumatic carditis. Prospective study of 40 episodes. Arq Bras Cardiol
1993; 60: 377–381.
Herdy, GV, Pinto, CA, Olivaes, MC, et al. Rheumatic carditis treated with high doses of pulsetherapy methylprednisolone. Results in 70 children over 12 years. Arq Bras Cardiol
1999; 72: 604–606.
Akçoral, A, Oran, B, Tavli, V, et al. Effects of high-dose intravenous methylprednisolone in children with acute rheumatic carditis. Acta Paediatr Jpn
1996; 38: 28–31.
Camara, EJN, Braga, JCV, Alves-silva, LS, et al. Comparison of an intravenous pulse of methylprednisolone versus oral corticosteroid in severe acute rheumatic carditis: a randomized clinical trial. Cardiol Young
2002; 12: 119–124.
Ilingworth, RS, Burke, J, Doxiadis, SA, et al. Salicylates in rheumatic fever: an attempt to assess their value. Q J Med
1954; 23: 177–213.
UK and US Joint Report. The natural history of rheumatic fever and rheumatic heart disease: cooperative clinical trial of ACTH, cortisone, and aspirin. Circulation
1965; 32: 457–476.
Illingworth, RS, Lorber, J, Holt, KS, et al. Acute rheumatic fever in children: a comparison of six forms of treatment in 200 cases. Lancet
1957; 273: 653–659.
Bywaters, EG, Thomas, GT. Bed rest, salicylates, and steroid in rheumatic fever. Br Med J
1961; 1: 1628–1634.
Paz, JA, Silva, CA, Marques-Dias, MJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol
2006; 34: 264–269.
Walker, AR, Tani, LY, Thompson, JA, et al. Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr
2007; 151: 679–683.
Fusco, C, Ucchino, V, Frattini, D, et al. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham’s chorea. Eur J Paediatr Neurol
2012; 16: 373–378.
Bitar, FF, Hayek, P, Obeid, M, et al. Rheumatic fever in children: a 15-year experience in a developing country. Pediatr Cardiol
2000; 21: 119–122.
Little, SG. The challenges of managing rheumatic disease of the mitral valve in Jamaica. Cardiol Young
2014; 24: 1108–1110.
Torres, RPA, Cunha, CLP, Miyague, NI. Estudo de 500 casos de febre reumática na cidade de Curitiba. Divulgação em Saúde para Debate
2000; 19: 73–75.